Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients
Trial
N/A
Completed
June 24, 2021
Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
Trial
N/A
Completed
June 22, 2021
Self-Reports of Executive Functions in Persons With Parkinson's Disease and Their Significant Others
Trial
N/A
Unknown
June 21, 2021
Cognitive Training in Parkinson's Disease, the iPARK Study
Trial
N/A
Unknown
June 21, 2021
Correlation Between Non-motor Symptoms and Malnutrition in Patients With Parkinson's Disease
Trial
N/A
Unknown
June 21, 2021
6-year Follow-up of Dysphagia in Patients With Parkinson's Disease
Trial
N/A
Unknown
June 15, 2021
Investigation of the Effects of Pilates Training in Parkinson Patients
Trial
N/A
Completed
June 15, 2021
Effects of Virtual Reality Versus Motor Imagery Versus Routine Physical Therapy in Patients With Parkinson's Disease.
Trial
N/A
Completed
June 15, 2021
Study on Serum Cystatin C and PET-DAT in Patients With Parkinson's Disease
Trial
N/A
Unknown
June 14, 2021
Neurorehabilitation of Sequence Effect in Parkinson's Disease
Trial
N/A
Completed
June 14, 2021
to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers
Trial
Phase 1
Unknown
June 7, 2021
Trans-spinal Magnetic Stimulation (TsMS) in Parkinson's Disease- Related Musculoskeletal Pain
Trial
N/A
Completed
June 7, 2021
Integrated Parkinson Care Networks : Care in Parkinson Disease
Trial
N/A
Unknown
June 6, 2021
Effects of Physical Therapy on Gait Parameters in Patients With Parkinson Disease
Trial
N/A
Completed
June 2, 2021
SHMT1 Polymorphism in Parkinson's Disease,
Trial
N/A
Unknown
June 1, 2021
A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease
Trial
Phase 2
Withdrawn
May 27, 2021
Deep Brain Stimulation Effects on Gait and Balance in Patients With Parkinson's Disease
Trial
N/A
Terminated
May 27, 2021
AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia
Trial
Phase 2
Unknown
May 25, 2021
Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.
Trial
N/A
Completed
May 24, 2021
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease
Trial
Phase 1
Terminated
May 24, 2021